Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch's pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation's first cancer prevention research program, as well as the clinical coordinating center of the Women's Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The Markey Lab is a newly established laboratory led by a physician-scientist and is seeking to recruit a post-doctoral fellow or a trainee hematologist/oncologist interested in pursuing laboratory-based research projects. The lab focuses on the intersection between the microbiome (and its metabolites) and post-transplant and/or post-immunotherapy immune function and clinical outcomes.
In this role, the candidate will be involved in projects that take clinical observational findings from studies of the intestinal microbiome (e.g. Markey et al, Blood 2020) through to mechanistic studies in mouse models. A number of observational studies have been performed supporting associations between the microbiome and transplant and/or immunotherapy outcome, but mechanistic data is currently lacking (e.g. Peled et al, NEJM 2020, Stein Thoeringer et al, Science 2020). Combining hypotheses generated from our clinical data with state of the art immunology techniques in mouse model systems is important for addressing the current knowledge gaps in the field and supporting the design of microbiome-targeted interventions in future.
A recent PhD, MD/PhD, or MD in a relevant biological field
Candidate is expected to have laboratory experience in mouse models, flow cytometry and sequencing methods
Excellent written and verbal communications skills are essential
A cover letter detailing interest in the position and names and contact details for three references are required.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and anti-racism in your career or that will be made through your work at Fred Hutch is requested of all finalists.